National Medical Care Co. · TADAWUL:4005
National Medical Care — FY2023 Earnings Presentation
21 slides from National Medical Care's earnings presentation, Feb 22, 2024
Slide 1: Earnings Presentation FY 2023
Earnings Presentation FY 2023
Slide 2: Performance Highlights and Strategy
Performance Highlights and Strategy
Slide 3: Operating and Financial Performance Highlights
Operating1 and Financial Performance Highlights Solid operational efficiency paired with rapidly improving financial outcomes Revenue Surgeries 651.2 Total patients 18,838 in FY 2023 thousand 1,082 SAR mn Inpatient 21.3 thousand admissions in FY 2023 302 Cash Flow From Operations EBITDA Number of Av
Slide 4: Care Growth Strategy
Care Growth Strategy Strategy stands to reshape the organization, boost Company's performance and transform patient care Strategic Objectives Extend Serve Deliver Realize A set of carefully designed initiatives underpins Care’s strategy Strategic Focus Areas Performance People & Organization Patient
Slide 5: Care Growth Strategy: Completed Strategic Initiatives
Care Growth Strategy: Completed Strategic Initiatives Finalized initiatives boost revenue, broaden segments, and strengthen patient and partner ties Expansion Operations Improvement Patients & Partners
Slide 6: Care Growth Strategy: Key Strategic Initiatives Underway
Care Growth Strategy: Key Strategic Initiatives Underway Ongoing initiatives centre around further organic and inorganic business growth Expansion
Slide 7: Operating and Financial Performance
Operating and Financial Performance
Slide 8: Operational Trends
Operational Trends1 Patient numbers growth driven by more referrals, offset by the completion of a significant contract SAR mn 4Q2023 4Q2022 Δ% FY2023 FY2022 Δ% Inpatient admissions 5,313 5,927 -10% 21,280 21,172 +1% Outpatient visits 169,752 172,784 -2% 629,930 617,495 +2% Total patients 175,065 17
Slide 9: Income Statement
Income Statement FY 2023 profitability improvement driven by steady operations, better pricing, and cost control efforts SAR mn 4Q2023 4Q2022 Δ% FY2023 FY2022 Δ% Revenues 300 252 +19% 1,082 918 +18% Cost of revenues (193) (173) +12% (712) (628) +13% Gross profit 107 79 +35% 370 290 +28% Operating ex
Slide 10: Revenue Trends
Revenue Trends Revenue in 2023 fueled by increasing number of referrals from key clients and price hikes 4 4 3 3 2 SAR 1,082mn 2 1 1 0
Slide 11: Costs Overview
Costs Overview Total expenses growth slower than the rise in revenue, creating a favourable operating leverage effect 4 4 3 3 2 SAR 835mn 2 1 1 0
Slide 12: Balance Sheet Highlights
Balance Sheet Highlights Solid balance sheet, marked by a significant cash reserve and a more efficient cash conversion cycle SAR mn 4Q2023 4Q2022 Δ% 3Q2023 Δ% Total Non-Current Assets 936 657 +43% 754 +24% Total Current Assets 1,278 1,056 +21% 1,157 +10% Total Assets 2,214 1,713 +29% 1,911 +16% Tot
Slide 13: Receivables Management
Receivables Management Better receivables management through the efficient clearance of GOSI's collections backlog
Slide 14: Cash Flow Highlights
Cash Flow Highlights Cash flow from operations supported by stronger results and improvement in working capital SAR mn 4Q2023 4Q2022 Δ% FY2023 FY2022 Δ% Net Profit before zakat 62 61 +2% 265 199 +33% Non-cash adjustments 20 9 +2.1x 54 68 -20% Working capital changes (115) 140 NA 158 (23) NA Zakat an
Slide 15: Q&A Session
WU TS Q&A Session Care Medical Earnings Presentation - 27/02/24
Slide 16: Appendix
WU TS Appendix Care Medical Earnings Presentation - 27/02/24
Slide 17: Operating Performance Overview (1/2)
Operating Performance Overview1 (1/2)
Slide 18: Operating Performance Overview (2/2)
Operating Performance Overview1 (2/2)
Slide 19: Financial Performance Overview
Financial Performance Overview
Slide 20: Contacts
Contacts Institutional investor contact
Slide 21: Disclaimer
Disclaimer All information included in this document is for general use only and has not been independently verified, nor does it constitute or form part of any invitation or inducement to engage in any investment activity, nor does it constitute an offer or invitation or recommendation to buy or su